ACADIA Pharmaceuticals (MEX:ACAD) Tax Rate %: 8.64% (As of Mar. 2026)


MEX:ACAD ACADIA Pharmaceuticals Inc MEX:ACAD
74 GF Score
Price MXN460.00
GF Value MXN442.46
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is ACADIA Pharmaceuticals Tax Rate %?

ACADIA Pharmaceuticals MEX:ACAD 74 Tax Rate % is 8.64% as of Mar. 2026. GuruFocus rates MEX:ACAD with a GF Score™ of 74/100 and a GF Value™ of MXN442.46 (Fairly Valued). The stock has 10 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. ACADIA Pharmaceuticals's Tax Expense for the three months ended in Mar. 2026 was MXN6 Mil. ACADIA Pharmaceuticals's Pre-Tax Income for the three months ended in Mar. 2026 was MXN72 Mil. Therefore, ACADIA Pharmaceuticals's Tax Rate % for the quarter that ended in Mar. 2026 was 8.64%.

ACADIA Pharmaceuticals Tax Rate % Related Terms

ACADIA Pharmaceuticals Tax Rate % Historical Data

* Premium members only.

The historical data trend for ACADIA Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACADIA Pharmaceuticals Tax Rate % Chart

ACADIA Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -1.19 -20.08 12.25 -181.49

ACADIA Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.65 33.68 -60.96 -939.43 8.64
MEX:ACAD
74GF Score
ACADIA Pharmaceuticals Inc MEX:ACAD
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACADIA Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

ACADIA Pharmaceuticals's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=-4539.165/2501.064
=-181.49 %

ACADIA Pharmaceuticals's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=6.203/71.788
=8.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 8.64% mean?
ACADIA Pharmaceuticals (MEX:ACAD) has a Tax Rate % of 8.64% as of Mar. 2026.
Is ACADIA Pharmaceuticals' Tax Rate % too high?
ACADIA Pharmaceuticals' current Tax Rate % is 8.64%. Overall, ACADIA Pharmaceuticals has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ACADIA Pharmaceuticals' Tax Rate % compare to VKTX and EWTX?
ACADIA Pharmaceuticals' Tax Rate % of 8.64% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. ACADIA Pharmaceuticals's current Tax Rate % is 8.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACADIA Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, ACADIA Pharmaceuticals (MEX:ACAD) is currently considered Fairly Valued. The stock's GF Value™ is MXN442.46, compared to a current price of MXN460.00 — trading 4% above its estimated fair value. The current Tax Rate % is 8.64%. ACADIA Pharmaceuticals' overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For ACADIA Pharmaceuticals (MEX:ACAD), the current Tax Rate % is 8.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACADIA Pharmaceuticals (MEX:ACAD) Overvalued in 2026?

Based on GuruFocus' analysis, ACADIA Pharmaceuticals stock appears to be overvalued. The current stock price of MXN460.00 is trading 4% above its estimated GF Value™ of MXN442.46. GuruFocus considers ACADIA Pharmaceuticals to be Fairly Valued.

Key valuation signals for MEX:ACAD:

  • Tax Rate %: 8.64%
  • GF Value™: MXN442.46 vs. price of MXN460.00 (4% above fair value)
  • GF Score™: 74/100 with 10 warning signs

No single metric tells the full story. See the MEX:ACAD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACADIA Pharmaceuticals Business Description

Other Exchanges ACAD:USADR6:Germany
Address 12830 El Camino Real, Suite 400, San Diego, CA, USA, 92130
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-211, ACP-711, ACP-2591, etc.
74GF Score

Get the complete analysis for MEX:ACAD

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN460.00
Price
MXN442.46
GF Value